pandem
due
sever
acut
respiratori
syndrom
coronaviru
tremend
consequ
societi
knowledg
seropreval
need
accur
monitor
spread
epidem
also
calcul
infect
fatal
rate
ifr
measur
may
help
author
make
inform
decis
adjust
current
societ
intervent
blood
donor
compris
approxim
similarli
age
popul
denmark
blood
donat
area
countri
object
studi
perform
realtim
seropreval
survey
among
blood
donor
tool
estim
previou
infect
popul
base
ifr
danish
blood
donor
age
year
give
blood
april
test
immunoglobulin
g
antibodi
use
commerci
later
flow
test
antibodi
statu
compar
area
estim
ifr
calcul
seropreval
adjust
assay
sensit
specif
take
uncertainti
test
valid
account
report
confid
interv
ci
result
first
blood
donor
test
combin
adjust
seropreval
ci
calcul
seropreval
differ
across
area
use
avail
data
fatal
popul
number
combin
ifr
patient
younger
estim
per
ci
infect
ifr
estim
slightli
lower
previous
report
countri
use
seropreval
data
ifr
includ
individu
comorbid
like
sever
fold
lower
current
estim
may
implic
risk
mitig
initi
realtim
nationwid
seropreval
survey
blood
donat
tool
monitor
epidem
human
suffer
pandem
due
sever
acut
respiratori
syndrom
coronaviru
local
sever
epidem
experi
countri
use
health
author
calibr
societ
intervent
intervent
eg
close
school
public
institut
prohibit
group
gather
even
curfew
tremend
consequ
author
reli
accur
realtim
data
make
inform
decis
thu
number
patient
test
posit
admit
hospit
need
respiratori
assist
deceas
coronaviru
diseas
updat
daili
basi
contrast
littl
inform
exist
percentag
popul
previou
mild
asymptomat
proport
popul
overcom
infect
probabl
approxim
test
antibodi
antibodi
may
confer
immun
repeat
infect
high
proport
immun
individu
attenu
epidem
measur
seropreval
also
use
estim
clinic
impact
statist
morbid
mortal
vari
greatli
due
vari
test
strategi
eg
capac
health
care
system
treat
infect
patient
countri
diagnos
mild
infect
report
lower
morbid
mortal
compar
less
comprehens
test
strategi
accur
measur
seropreval
use
estim
accumul
number
infect
thu
infect
fatal
rate
ifr
underli
popul
blood
donor
compris
approxim
danish
popul
age
group
healthi
volunt
donat
blood
area
countri
ensur
wide
geograph
coverag
initi
prospect
screen
blood
donat
antibodi
establish
realtim
nationwid
overview
antibodi
statu
object
studi
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
combin
rate
either
igm
andor
igg
posit
valid
test
perform
experienc
staff
five
region
blood
establish
retriev
data
popul
number
januari
st
number
infect
deceas
due
use
daili
updat
data
statist
analysi
perform
rstudio
r
result
report
percentag
confid
interv
ci
epir
packag
use
adjust
seropreval
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
sensit
specif
use
rogan
gladen
estim
calcul
true
preval
ci
deriv
percentil
bootstrap
independ
sampl
sensit
specif
appar
preval
use
binomi
distribut
antibodi
test
perform
routin
screen
blood
donat
consent
donor
test
inform
result
anonym
data
use
studi
region
scientif
ethic
committe
zealand
region
denmark
approv
investig
regist
project
includ
blood
donor
age
year
total
blood
donor
inform
consent
test
see
tabl
characterist
distribut
seroposit
igm
igg
appear
tabl
estim
number
infect
individu
calcul
per
area
relev
age
group
tabl
overal
unadjust
seropreval
ci
adjust
assay
sensit
specif
includ
ci
overal
seropreval
ci
seropreval
capit
region
higher
four
region
combin
vs
differ
percentag
point
ci
april
individu
report
die
denmark
younger
thu
combin
ifr
patient
younger
estim
per
infect
ci
total
ratio
estim
antibodyposit
individu
number
confirm
case
ci
survey
antibodi
danish
blood
donor
found
seropreval
ci
adjust
assay
perform
low
ifr
ci
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
ifr
slightli
lower
recent
publish
ifr
estim
ci
individu
year
includ
seropreval
data
ratio
estim
antibodyposit
individu
confirm
case
expect
given
target
earli
danish
test
strategi
lack
larg
seropreval
survey
prevent
comparison
areascountri
low
ifr
encourag
sever
caveat
exist
although
blood
donor
repres
broad
popul
base
select
healthi
selfdef
two
week
sign
convers
blood
donor
preval
increas
incom
specul
lead
higher
risk
exposur
travel
social
activ
may
therefor
either
overestim
true
popul
immun
valid
antibodi
assay
primarili
individu
diagnos
clinic
silent
mild
infect
lead
weaker
antibodi
respons
underestim
popul
immun
also
screen
antibodi
may
underestim
preval
infect
cellular
cytotox
abl
erad
viral
infect
cell
sarscov
elicit
humor
respons
final
studi
address
ifr
individu
ifr
popul
strata
eg
among
individu
comorbid
higher
current
govern
countri
tri
balanc
econom
consequ
societ
lockdown
risk
uncontrol
epidem
result
underpin
social
distanc
healthi
popul
predomin
act
mean
protect
vulner
individu
would
challeng
perform
unbias
seropreval
survey
background
popul
blood
donat
facil
locat
nationwid
oper
continu
screen
suit
monitor
region
differ
tempor
chang
greater
knowledg
seropreval
popul
strata
continu
monitor
may
also
use
effect
model
activ
epidem
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
undertook
valid
found
less
perfect
sensit
previou
pcrconfirm
patient
test
howev
known
infect
individu
produc
antibodi
specif
accept
lead
low
posit
predict
valu
lowpreval
area
use
conserv
method
estim
confid
interv
thu
took
sampl
variat
also
uncertainti
sensit
specif
account
necessari
unlik
diagnost
screen
test
gold
standard
confirm
posit
neg
result
confid
interv
region
lowest
antibodi
preval
thu
reach
lower
limit
seropreval
estim
ifr
allow
lag
time
infect
death
base
current
literatur
time
infect
death
nonsurvivor
day
similarli
lag
time
infect
detect
antibodi
may
day
donor
selfdeferr
due
respiratori
symptom
add
lag
time
detect
antibodi
use
last
avail
total
deceas
citizen
due
april
use
earlier
valu
would
result
lower
ifr
estim
wait
later
death
toll
would
result
higher
ifr
death
toll
among
citizen
year
use
even
though
death
appear
among
individu
comorbid
chosen
denomin
includ
citizen
age
strata
thu
also
individu
comorbid
ifr
includ
individu
comorbid
thu
like
sever
fold
lower
current
estim
result
includ
articl
updat
freeli
access
http
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
result
indic
ifr
among
individu
age
year
ci
may
implic
risk
mitig
ifr
older
popul
strata
may
consider
higher
nationwid
continu
seropreval
survey
blood
donat
may
tool
monitor
epidem
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
tabl
tabl
femal
male
age
sex
stratifi
seropreval
sampl
stratifi
accord
detect
igm
igg
antibodi
isotyp
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
